Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Junior/Mid Software Engineer

Mytos
CompanyMytos
CategoryEngineering
LocationLondon
RemoteHybrid
EmploymentFull-time
LevelEntry
SalaryNot stated by the employer
Posted17 Mar 2025
Last verified30 Jul 2026
SourceEmployer career page (lever)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
About Mytos You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.   We’ve developed machines to fully automate human cell production - the most manual process in Biotech. Cells are used to discover and develop new drugs, and now they're being used to cure diseases like Parkinson’s and age-related blindness. Mytos will impact cure development across the board.   We're live in multibillion dollar biotechs on both coasts of the US, and raised $19m to expand into the market faster, and accelerate our development! Next year, neurons grown on our machines will be going into Parkinson patient brains.   We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team   Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.   The Role As a Junior/Mid level Software Engineer (depending on experience) you’ll be contributing across all areas of our full-stack product based in the Cloud, and our IoT devices that interface with Mytos hardware to manufacture cells. You'll contribute across a variety of technologies and paradigms, leaning how to research, design, implement, maintain, and evolve product functionality giving users powerful tools to customise and monitor cell growth protocols.   Your work will directly impact how quickly and effectively new therapies and research tools can be developed, ultimately helping patients worldwide.
HOUSE AD970,107 openings. Erioun finds yours.Scored against your own profile, every hour.Try the radar →